FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 862190 · Received June 4, 2007

Report

Report Number
2954730-2007-00243
Event Type
Malfunction
Date Received
June 4, 2007
Date of Event
May 16, 2007
Report Date
May 22, 2007
Manufacturer
HEMOSENSE, INC.
Product Code
JPA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

INRATIO PRECISION DATA PROVIDED BY END-USER LOT 060656: FIRST TEST INR = 7.5, SECOND TEST INR = 7.5, MEAN = UNABLE TO BE DETERMINED ; SD = UNABLE TO BE DETERMINED ; %CV = UNABLE TO BE DETERMINED %. FIRST TEST INR = 4.7 SECOND TEST INR = 3.2, MEAN = 3.55; SD = 1.06; %CV = 26.9%. FIRST TEST INR = 3.9 SECOND TEST INR = 3.1, MEAN = 3.5; SD = 0.57; %CV = 16.1. THE %CV IS LESS THAN OR EQUAL TO 20%. PER INTERNAL PROCEDURE, THE PRECISION PASSES THE CRITERIA FOR PRECISION. THE TEST IS CONSIDERED PRECISE AND NO FURTHER TESTING IS REQUIRED AT THIS TIME. DISCREPANT RESULTS (ACCURACY) COMPARISON OF INRATIO TEST WITH LAB RESULTS PROVIDED BY END-USER AT TIME COMPLAINT WAS FILED: DATE: 5/2007, INRATIO: 4.9, LAB: 4.7, MEAN: 4.8, CONFIDENCE LIMITS: 2.8-7.2. PER INTERNAL PROCEDURE, THE MEAN OF THE INRATIO METER AND COMPARATIVE SYSTEM INR WERE CALCULATED. BOTH INRATIO AND LAB VALUES ARE WITHIN THE CONFIDENCE LIMITS FOR INR TESTING. THE RESULTS ARE NOT CONSIDERED DISCREPANT WITHIN THE CONTEXT OF THE DOCUMENTED VARIABILITY FOR INR TESTING. THEREFORE, FURTHER TESTING IS NOT REQUIRED AT THIS TIME.

Description of Event or Problem · 1

CALLER ALLEGED IMPRECISION WITH INRATIO. RESULTS AS FOLLOWS: SEE SCANNED TABLE. CALLER ALLEGED INACCURACY WITH INRATIO. RESULTS AS FOLLOWS: DATE: 5/2007, INRATIO: 4.9, LAB: 4.7.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST JPA HEMOSENSE, INC. 060656

Patients

Seq Age Sex Outcome Treatment
1 YR